According to reports,Elon Musk's Neuralink company has made a major breakthrough - its brain-computer interface device Link recently received "breakthrough device" certification from the U.S. Food and Drug Administration (FDA).It will bring revolutionary communication solutions to patients with severe speech disorders. This certification marks a new stage in the integration of human cognition and technology.
The device is mainly intended for patients with neurological diseases such as amyotrophic lateral sclerosis (ALS), stroke, and spinal cord injury.The latest announced case shows that the third PRIME study participant, ALS patient Bradford Smith, successfully restored his communication ability by implanting a Link device.What’s amazing is that he can not only use his mind to control the computer cursor to input text, but he can also use AI-synthesized personal voices to express himself, and even completed the editing of demonstration videos independently.
"I'm typing this text into my brain, which is my primary method of communication now," Smith wrote in the video. Compared with the eye-tracking devices that were previously relied on, Link brings a higher degree of freedom of use and environmental adaptability.
Neuralink's technical layout is rapidly expanding. In addition to the recovery of language functions, its visual recovery device Blindsight also received FDA breakthrough certification in 2024. The company is currently expanding the scope of global patient recruitment, focusing on promoting PRIME basic function research and CONVOY external device control research.
According to people familiar with the matter, Neuralink is preparing for a new round of financing of up to US$500 million, with a pre-money valuation of approximately US$8.5 billion.This series of progress not only demonstrates the huge potential of brain-computer interface technology, but also brings unprecedented hope to patients with neurological diseases. As clinical trials expand, this breakthrough technology has the potential to revolutionize the quality of life for people with severe speech impairments.
